Home Quality Improvement Lipid QI Programme Module 2 Lipid Quality Improvement (QI) Programme Module 2: Recall and Review - practical tips This programme has been solely funded by Novartis. Novartis were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by PCCS. These modules were filmed in November 2023, which was prior to the publication of the updated NICE guideline NG238. As a result, throughout the videos reference is made to NICE CG181. The information provided in this presentation is for educational purposes only. Prescribing or management decisions made by clinicians are exclusively their own responsibility. The speaker/PCCS bear no responsibility regarding management or prescribing decisions made by others, or otherwise. Downloadable slides Speakers: Prof Raj Thakkar & Dr Jim Moore Please click here to download Resources Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS UCLPartners Proactive Care Framework: Lipid Management including Familial Hypercholesterolaemia NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification (CG181) NICE CKS Lipid modification - CVD prevention Quality and Outcomes Framework guidance for 2023/24 For further PCCS resources and guidance, check out our Lipids module on the CVD Academy! Useful links QRISK®3-2018 risk calculator NHS Health Check Interested in Putting the Theory into Practice? Read more here. Quality Improvement Programme COVID-19 & CVD QI Programme IntroductionModule 1Module 2Module 3CKD QI Programme IntroductionModule 1Module 2Module 3Module 4Lipid QI ProgrammeModule 1 Module 2Module 3 Module 4 Additional ResourcesHeart Failure QI ProgrammeOberoi Disease Management Digital Audit Platform Explore PCCS Member Benefits